The Technical Analyst
CEN Biotech, Inc. [CENBF]
Exchange: OTC Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
CEN Biotech, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $0.0033
America/New_York / 1 mai 2024 @ 12:41
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 0.564 mill |
| EPS: | -0.0300 |
| P/E: | -0.110 |
| Earnings Date: | Mar 31, 2023 |
| SharesOutstanding: | 171.00 mill |
| Avg Daily Volume: | 0.0019 mill |
| RATING 2024-05-01 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Buy | |
| DE: | Strong Sell | |
| P/E: | Neutral | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.110 | sector: PE 29.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.00x |
| Company: PE -0.110 | industry: PE 31.46 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0003 - 0.0063 ( +/- 90.91%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2021-12-06 | Purdy Rick Leigh | Buy | 2 500 000 | Common Stock |
| 2021-07-09 | Lehoux Lawrence | Sell | 0 | Common Stock |
| 2021-06-25 | Tarrabain Alex | Buy | 1 000 000 | Common Stock |
| 2021-06-16 | Tarrabain Alex | Buy | 3 000 | Common Stock |
| 2021-04-02 | Aubrey De Lavenu Harold Andre | Buy | 1 041 250 | Common Stock |
| INSIDER POWER |
|---|
| 0.00 |
| Last 36 transactions |
| Buy: 13 945 301 | Sell: 1 053 878 |
Forecast: